Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nestle Skin Health SA

Division of Nestle SA
www.nestle.com

Latest From Nestle Skin Health SA

Differin Gel Enters Changed Marketplace Since Last OTC Acne Drug Approval

Galderma Labs' adapalene gel is pending launch as first OTC acne ingredient approved through an NDA and first new acne ingredient available OTC in 20 years, but company must play in a digitally-oriented marketplace.

Prescription To Otc Switch Dermatology

Differin Gel Enters Changed Marketplace Since Last OTC Acne Drug Approval

Galderma Labs' adapalene gel is pending launch as first OTC acne ingredient approved through an NDA and first new acne ingredient available OTC in 20 years, but company must play in a digitally-oriented marketplace.

Prescription To Otc Switch Dermatology

Nestle's Prospects To Lead OTC Acne Market Gel With Differin Approval

Differin Gel, the first NDA approved OTC acne treatment, could make Nestle the runaway leader in the market. The Swiss firm's Nestle Skin Health business owns Differin maker Galderma and has a majority stake in a JV marketing Proactiv.

United States Prescription To Otc Switch

Nestle's Prospects To Lead OTC Acne Market Gel With Differin Approval

Differin Gel, the first NDA approved OTC acne treatment, could make Nestle the runaway leader in the market. The Swiss firm's Nestle Skin Health business owns Differin maker Galderma and has a majority stake in a JV marketing Proactiv.

United States Prescription To Otc Switch
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
    • OTC, Consumer
  • Therapeutic Areas
  • Dermatology
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • Nestle SA
  • Senior Management
  • Humberto C Antunes, CEO
    Torsten Koster, CFO
    Johannes Baensch, PhD, CSO
    Peter Nicholson, VP, Bus. Dev. & Strategy
  • Contact Info
  • Nestle Skin Health SA
    Phone: 21 924 1111
    Ave Nestle 55
    Vevey, 1800
    Switzerland
Advertisement
Advertisement
UsernamePublicRestriction

Register